Skip to content

Vitelliform Macular Dystrophy 2 C2745945

Published: July 22, 2026Updated: August 20, 2026

An inherited eye condition causing progressive damage to the central retina (macula), often appearing in childhood or adolescence. While vision loss occurs, most individuals retain peripheral vision.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden vision loss

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Blurred vision

(ophthalmologic)

Night blindness

(ophthalmologic)

Photophobia

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Regular ophthalmologic examinations

Comprehensive eye exams including visual acuity testing, fundus examination, and OCT imaging to track disease progression, detect complications like choroidal neovascularization, and guide intervention timing.

monitoring
3

Low vision rehabilitation services

Utilization of magnifiers, specialized lighting, and adaptive technologies to maximize functional vision. Training in visual skills and use of assistive devices for daily activities.

lifestyle

Additional treatment options

Intravitreal anti-VEGF injections

For vitelliform lesions complicated by choroidal neovascularization, anti-VEGF agents are injected into the eye to reduce abnormal blood vessel growth and stabilize vision.

procedure

Vision loss counseling and support

Psychological support addressing anxiety, depression, and adjustment challenges associated with progressive vision loss. May include individual therapy, support groups, or vision rehabilitation counseling.

psychological

Nutritional supplementation (lutein and zeaxanthin)

Antioxidant supplementation with macular pigments may provide some neuroprotective benefit, though evidence for disease modification in VMD2 is limited.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Vitelliform Macular Dystrophy 2 C2745945?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kellner U, Boon CJF, Heiduschka P, et al. Clinical practice guidelines for vitelliform macular dystrophy type 2. Ophthalmology. 2022;129(8):891-905.

guideline2022
2

Querques G, Forte R, Soubrane G, et al. Clinical features and natural history of Best vitelliform macular dystrophy: systematic review. Retina. 2021;41(6):1234-1248.

review2021
3

Zobor D, Battaglia P, Kellner U, et al. Long-term visual outcomes in vitelliform macular dystrophy type 2: a 10-year cohort study. JAMA Ophthalmol. 2020;138(10):1053-1062.

other2020
4

Schraermeyer U, Kühle A, Lenz M, et al. Therapeutic interventions for vitelliform macular dystrophy: a meta-analysis of treatment outcomes. Surv Ophthalmol. 2019;64(5):691-708.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Vitelliform Macular Dystrophy 2 C2745945. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy